Press Release: Bavarian Nordic – Transactions in Connection with Share Buy-Back Program | Globe NewsWire News Distribution Service

Choose a language:

Globe NewsWire News Distribution Service

Details: Written by Globe NewsWire Press Releases; Category: Globe NewsWire News Distribution Service; Published: 07 September 2026; Created: 07 September 2026; Last Updated: 07 September 2026

COPENHAGEN, Denmark, September 7, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on September 1, 2026, under which the Company will repurchase shares for an amount up to DKK 250 million in the period from September 1, 2026 to October 30, 2026. The program is executed in accordance…

Posted: 2026-09-07 07:00:00

Get Full News Story On GlobeNewsWire Press Release Service

More News From This Category
Press Release: Willis appoints Trevor Madden as Head of Captive and Insurance Management Solutions, Asia Pacific
Mon, 07 Sep 2026 04:08:24 +0000

SINGAPORE, Sept. 07, 2026 (GLOBE NEWSWIRE) -- Willis, a WTW business (NASDAQ: WTW), today announced the appointment of Trevor Madden as Head of Captive and Insurance Management Solutions, Asia Pacific, effective 1 November 2026.

Press Release: MoneySimpler Enhances AI Automated Trading With Real-Time Market Analysis
Mon, 07 Sep 2026 01:08:35 +0000

MoneySimpler has upgraded its AI-powered automated trading platform to help users manage digital asset transactions more efficiently

Press Release: PHH、BYAH 最後期限：領先的投資者法律顧問 ROSEN 鼓勵損失超過 10 萬美元的 Park Ha Biological Technology Co., Ltd. 投資者在對 PHH、BYAH 提出證券集體訴訟的重要截止日期前聘請律師
Sun, 06 Sep 2026 22:08:17 +0000

紐約, Sept. 07, 2026 (GLOBE NEWSWIRE) -- 事因：全球投資者權益律師事務所 Rosen Law Firm 提醒於 2024 年 12 月 27 日至 2025 年 7 月 8 日（包括首尾兩日）（下稱「集體訴訟期」）購買 Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) 證券的人士注意，首席原告的重要截止日期為 2026 年 9 月 28 日。

Press Release: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRY
Sun, 06 Sep 2026 19:08:22 +0000

NEW YORK, Sept. 06, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March 9, 2026 and June 24, 2026, inclusive (the “Class Period”), of the important October 5, 2026 lead plaintiff deadline.

Related Bing News Results